Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials
暂无分享,去创建一个
E. Myers | M. Diamond | B. Carr | K. Chwalisz | E. Stewart | Alistair R W Williams | A. Williams | R. Feldman | W. Elger | C. Mattia-Goldberg | B. Schwefel | W. Elger | E. Stewart | M. Diamond | C. Mattia‐Goldberg